XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Clinical trial NCT06959641 · RECRUITING

Trial details

NCT number: NCT06959641
Sponsor: Jochen Lorch
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Differentiated Thyroid Gland Carcinoma Locally Advanced Poorly Differentiated Thyroid Gland Carcinoma Locally Advanced Thyroid Gland Follicular Carcinoma Locally Advanced Thyroid Gland Oncocytic Carcinoma Locally Advanced Thyroid Gland Papillary Carcinoma Metastatic Differentiated Thyroid Gland Carcinoma Metastatic Poorly Differentiated Thyroid Gland Carcinoma Metastatic Thyroid Gland Follicular Carcinoma Metastatic Thyroid Gland Oncocytic Carcinoma Metastatic Thyroid Gland Papillary Carcinoma Refractory Differentiated Thyroid Gland Carcinoma Refractory Poorly Differentiated Thyroid Gland Carcinoma

Start date: 2025-06-06
Primary completion: 2028-09-11
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.